These findings indicate that XRCC1 expression varies significantly across different immune and molecular subtypes in various human cancer types, highlighting the potential involvement of XRCC1 in distinct tumor microenvironments and molecular pathways. This evidence concerns the gene XRCC1 and neoplasm.